The UICC-led ATOM Coalition has seen encouraging progress since its launch on 20 May 2022 in expanding access to quality assured cancer medicines and diagnostics in LLMICs. The next phase focuses on country uptake, readiness, and impact on people living with cancer. 

Cancer planners from around the world met in Geneva to share lessons on turning national cancer control plans from policy documents into funded, implemented action.

After decades of stalled efforts, Jordan has endorsed its first national cancer control strategy, laying the groundwork for a more coordinated and equitable response to cancer, according to Dr Omar Nimri, epidemiologist and public health expert with the Jordan Center for Disease Control (JCDC) and President of the Jordan Cancer Society.

From community outreach to chemotherapy delivery, oncology nurses are the backbone of cancer care delivery. UICC marks International Nurses Day on 12 May with interviews with Peter Fore of the Papua New Guinea Oncology Nurses Association and Isabella Naana Asante of Embrace Society in Ghana, a UICC member.

For the second year, UICC is convening this week in Geneva national cancer planners and health officials from around the world who are working to develop and implement cancer strategies efforts and foster cross-country collaboration in health system development.

A new UICC report shows how countries translate cancer plans into real‑world impact, highlighting the governance, financing, and partnerships needed to implement national cancer control plans effectively.

On the occasion of IARC’s 60th anniversary, Director Dr Elisabete Weiderpass speaks about how independent research on cancer risk, data and prevention can better inform policy, and how to ensure that evidence is consistently translated into action.

The Access to Oncology Medicines (ATOM) Coalition partner Cepheid has made its first mRNA precision diagnostics for chronic myeloid leukaemia (CML) monitoring available to low- and lower-middle-income countries (LLMICs).